AIMM Therapeutics
-
2004
Company Description
production of monoclonal antibodies by immortalisation of B cells from elite patients.
AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that are obtained from individuals who have overcome disease or from immunized animals.
-
Manufacturer:
Science and Engineering -
Formed:
2004 -
Founders:
Hergen Spits -
Company Website:
-
Company E-mail:
-
Company Address:
Meibergdreef 59AmsterdamNetherlands -
CEO:
- Hergen Spits
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits